Who ships compounded tirzepatide to Utah
- Collective: $69 a month
- Eden: $129 a month
- CoreAge Rx: $129 a month
- Embody: $129 a month
- SnagRx: $149 a month
Every program on our compounded tirzepatide chart ships to Utah. The full chart has every price.
Does Utah Medicaid cover Zepbound?
Utah Medicaid does not cover Zepbound for weight loss. It does cover Zepbound for obstructive sleep apnea, with prior authorization. Utah Medicaid plans include Healthy U (University of Utah Health Plans), Molina Healthcare of Utah, SelectHealth Community Care and Health Choice Utah.
Utah Medicaid stopped covering GLP-1s for weight loss on June 30, 2026. A one-year pilot ran July 1, 2025 through June 30, 2026, funded by an appropriation rather than standing law, and it was not renewed. It also only ever applied to fee-for-service members, so anyone in a managed-care plan (Molina, SelectHealth, Healthy U, Health Choice) never had it. Utah's prior-authorization form was renamed 'GLP-1 Medications for Weight-related Comorbidities' on June 1, 2026 and the obesity approval criteria were removed, so there is no approval path left. Other uses continue: type 2 diabetes, heart-attack and stroke risk reduction (Wegovy injection or pill, BMI 27 or higher with a prior heart attack, stroke or symptomatic peripheral artery disease, and you must already be on prevention therapy), sleep apnea (Zepbound, BMI 30 or higher with an AHI of 15 or higher) and MASH, a fatty liver disease (Wegovy injection, fibrosis F2 to F3).
The Utah Medicaid drug list was last reviewed July 1, 2026. Utah Medicaid GLP-1 rules.
GLP-1 prescriptions Utah Medicaid paid for
| Quarter | Prescriptions | Medicaid paid | Per prescription |
|---|---|---|---|
| Apr to Jun 2025 | 4,597 | $4.8 million | $1,050 |
| Jul to Sep 2025 | 4,812 | $5.0 million | $1,050 |
| Oct to Dec 2025 | 5,350 | $5.6 million | $1,040 |
| Jan to Mar 2026 | 5,633 | $5.7 million | $1,020 |
Utah Medicaid paid for 5,633 GLP-1 prescriptions in the first quarter of 2026, up 23% from 4,597 in the second quarter of 2025.
Source: CMS State Drug Utilization Data, all GLP-1 brands, before rebates.
Obesity and insurance in Utah
29.8% of adults in Utah had obesity in 2025, by the CDC's state survey, against 33.5% for the US as a whole. 10.5% of Utah residents have no health insurance and 9.0% live below the poverty line (Census SAIPE 2023). Of the largest counties, Tooele County has the highest adult obesity rate, 37.6% (CDC PLACES 2025).
| County | Adults with obesity | No health insurance | Below the poverty line |
|---|---|---|---|
| Salt Lake County | 29.9% | 11.6% | 9.5% |
| Utah County | 29.7% | 9.6% | 9.0% |
| Weber County | 34.7% | 11.3% | 8.5% |
| Washington County | 33.1% | 10.0% | 10.6% |
| Davis County | 32.7% | 8.8% | 6.0% |
| Cache County | 27.9% | 9.7% | 10.7% |
| Iron County | 35.3% | 10.0% | 11.6% |
| Tooele County | 37.6% | 10.7% | 6.8% |
| Box Elder County | 32.6% | 10.3% | 8.5% |
| Uintah County | 35.5% | 11.3% | 11.1% |
Source: CDC PLACES 2025 for obesity, Census SAIPE 2023 for insurance and poverty.
More for Utah
- Every GLP-1 price in Utah
- Utah Medicaid and GLP-1s
- Free and low-cost help in Utah
- GLP-1 clinical trials in Utah
- Compounded tirzepatide in other states
Compounded tirzepatide is made by a licensed pharmacy to a prescription and is not FDA-approved. A prescriber decides whether it suits you.